Welcome to our dedicated page for Allstate SEC filings (Ticker: ALL), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Allstate’s 10-K can exceed 300 pages of loss triangles, catastrophe risk tables, and actuarial jargon—enough to overwhelm even seasoned analysts. If you are digging for Allstate insider trading Form 4 transactions before earnings or trying to trace reserve changes buried deep in footnotes, the search can feel endless.
Stock Titan solves that problem. Our AI reads every Allstate quarterly earnings report 10-Q filing, flags segment profitability swings, and delivers Allstate Form 4 insider transactions real-time to your dashboard. Get Allstate SEC filings explained simply; each note is paired with bite-sized context so you can move from raw document to Allstate earnings report filing analysis in minutes. Interactive filters help in understanding Allstate SEC documents with AI, highlighting where catastrophe losses hit income, how investment gains flow through results, and which geographies drive combined ratios.
Need governance details? Drill into the Allstate annual report 10-K simplified section for reserve adequacy discussions, open the Allstate proxy statement executive compensation snapshot to see incentive structures, or track risk disclosures through Allstate 8-K material events explained. Professional investors monitor Allstate executive stock transactions Form 4 alongside claim-severity trends; our platform puts both in one place, updated the moment EDGAR posts. Save hours, surface the metrics that move the stock, and make better decisions with AI-powered clarity.
Sezzle Inc. (ticker SEZL) has filed a Form 144 indicating the intention to sell 3,000 common shares through Fidelity Brokerage Services on or about 01 July 2025. The proposed sale is valued at approximately $528,240, representing less than 0.01 % of the 33.29 million shares outstanding. During the preceding three months, related parties—primarily Stacy Paradis and Paul V. Paradis—have already sold an aggregated 125,200 shares for roughly $9.7 million, suggesting an ongoing insider-selling program. Shares were originally acquired via restricted-stock vesting on 13 October 2016 and are being sold under Rule 144, which requires the filer to affirm no possession of undisclosed materially adverse information. While the filing is routine and the amount modest relative to float, continued insider sales may raise questions about executive confidence and could exert marginal selling pressure.